A preliminary study found that adults with type 2 diabetes and a moderate or high risk of cardiovascular disease were less likely to experience a serious cardiovascular event when taking low-dose ...

Bayer noted that many U.S. consumers of Hispanic origin grew up with Bayer’s Aspirina. Their parents and grandparents relied on it, instilling trust and nostalgia for the brand. Due to those deep ...

BERLIN, Nov 23 (Reuters) - German pharma company Bayer (BAYGn.DE), opens new tab reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the ...

Bayer has built a home for Chinese biopharma companies. Located in Beijing, the Bayer E-Town Open Innovation Center will incubate local biotechs starting with Puhe BioPharma and Youngen Technology.

FRANKFURT, Nov 24 (Reuters) - Shares in Bayer (BAYGn.DE), opens new tab jumped more than 8% on Monday after initial clinical trial results turned around the fortunes of a key cardiovascular drug that ...

BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.

Bayer's third-quarter sales came in a bit higher than anticipated, but the company is girding its loins for a challenging period ahead as generic competition and litigation liabilities bed in. Pharma ...

Just a few months after Boehringer Ingelheim broke into the oncology space with the first drug that can target a rare tumor type in patients with non-small cell lung cancer (NSCLC), the FDA has given ...

Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode ...

Bayer AG said an experimental stroke-prevention drug showed positive results in a late-stage clinical study, a boost for the German company as it seeks to counter sales declines from aging blockbuster ...

The study drug BAY 3401016 is a monoclonal antibody that blocks a protein called Semaphorin 3A (Sema3A), which is thought to be involved in the progression of kidney damage in Alport Syndrome (AS). By ...

Readers recall old-time remedies and products — from laxatives and tonics to cough drops and baby aspirin — sharing nostalgic memories of bygone brands.